Abstract Details

Title Predicting the End of Symptomatic Relapses and Disease Modifying Treatment Use Decisions in Progressive Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 001

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Orhun H. Kantarci, MD PRESENTER	Dr. Kantarci has nothing to disclose.
Martina Novotna (Mayo Clinic)	No disclosure on file
Brittani L. Conway, MD (University of Minnesota)	Dr. Conway has nothing to disclose.
	No disclosure on file
M. M. Paz Soldan, MD, PhD (Mayo Clinic)	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Nuhad Abou Zeid, MD (Wake Forest Baptist Medical Center)	No disclosure on file
Nilufer Kale, MD	Dr. Kale has nothing to disclose.
Melih Tutuncu, MD	No disclosure on file

��ɫ��